This comes as markets continue to witness sharp downswings and muted recoveries, with oil prices remaining elevated amid the seesaw politic...

SpaceX's huge IPO is set to capture global attention. However, experts believe this event may not reflect the true health of the broader IP...

Hong Kong's stock market is seeing more foreign companies file for listings. Firms from countries like Indonesia and South Korea are explor...

Flipkart has hit pause on its IPO in a jittery market. This and more in today's ETtech Top 5.

Odyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...

HawkEye 360's stock surged 30% on its Thursday debut, reaching a $3.15 billion valuation after raising $416 million in its U.S. IPO. The de...

Happy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...

U.S. firms may soon have the option to report earnings semi-annually instead of quarterly, a proposal revived by President Trump. While pro...

China's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development initiatives. This enviro...

Kailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....

Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The ...

Dheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...

Companies across sectors have resumed IPO roadshows despite Middle East tensions, signalling pent-up demand in the pipeline. Analysts expec...

India's Biotechnology Industry Research Assistance Council, BIRAC, marked its 14th Foundation Day. It has significantly boosted India's bio...

India must create a special listing framework for research-stage companies on its stock exchanges. This will unlock capital for biotech and...

Out of the 10 issues, four have seen their share prices more than double from issue prices.